Bulletin of Experimental Biology and Medicine

, Volume 119, Issue 2, pp 120–123 | Cite as

Neurotropic effects of a luliberin analog administered intraventricularly to rats with different sensitivities to ethanol

  • L. A. Sever'yanova
  • I. I. Bobyntsev
Pathological Physiology and General Pathology
  • 16 Downloads

Abstract

In experiments with random-bred male rats separated into short and long sleepers according to the duration of ethanol-induced sleep (narcosis), a synthetic luliberin analog (Surfagon) administered into a brain ventricle was found to reduce pain sensitivity and affective aggressiveness in response to unavoidable painful electrostimulation, and to increase convulsive activity. Short-sleeping rats differed from long-sleeping ones in showing greater behavioral excitability and aggressiveness and in being more responsive to Surfagon, which lowered both these parameters in the former rats to a greater extent than in the latter before castration as well as after it. Mechanisms of the observed behavioral effects of Surfagon are discussed, and it is concluded that they are not mediated by sex steroids, and that the major factor in the mechanisms of its action is the accessibility of limbic structures and of the central gray substance in the midbrain.

Key Words

luliberin Surfagon stress aggressive/defensive behavior alcohol motivation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    I. I. Bobyntsev, L. A. Sever'yanova, and Yu. D. Lyashev,Byull. Eksp. Biol. Med.,112, No 12, 612–615, (1991).Google Scholar
  2. 2.
    Yu. V. Burov and N. N. Vedernikova,Neurochemistry and Pharmacology of Alcoholism [in Russian], Moscow (1985).Google Scholar
  3. 3.
    L. A. Sever'yanova,Influence of Adaptive Hormones on the Integrative Activity of the Brain [in Russian], Moscow (1988).Google Scholar
  4. 4.
    B. J. Crain, K. J. Chang, and J. W. McNamara,Brain Res.,412, No 2, 343–351 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Gambacciani, S. S. C. Yen, and D. D. Rasmussen,Life Sci.,43, No 9, 755–760 (1988).PubMedCrossRefGoogle Scholar
  6. 6.
    F. Havour, M. Dussaillant, P. Leblanc, and W. Rostene,C.R. Acad. Sci. (Paris), (Ser. 3),305, No 2, 41–44 (1987).Google Scholar
  7. 7.
    J.-F. Heurtier, E. Ban, M. Crumeyrolle, and F. Havour,Neuroendocrinology,52, Suppl. 1, 80 (1990).Google Scholar
  8. 8.
    L. Jennes,Gen. Comp. Endocrinol.,74, No 2, 288–289 (1989).Google Scholar
  9. 9.
    P. Leblanc, M. Crumeyrolle, L. Jacquelle,et al., Neuroendocrinology,49, No 5, 482–488 (1988).Google Scholar
  10. 10.
    J. Merchenthaller, G. Setalo, P. Patrusz,et al., Exp. Clin. Endocrinol.,94, No 5, 482–488 (1988).Google Scholar
  11. 11.
    A. Oliverio, C. Costellano, and S. Puglisi-Allegra,Int. Rev. Neurobiol.,25, 277–337 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    L. J. Pellegrino, A. S. Pellegrino, and A. J. Cushman,A Stereotaxic Atlas of the Rat Brain, New York-London (1979).Google Scholar
  13. 13.
    M. Sheard,Aggres. Behav.,7, No 1, 41–49 (1981).Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • L. A. Sever'yanova
    • 1
  • I. I. Bobyntsev
    • 1
  1. 1.Department of Pathological PhysiologyState Medical InstituteKursk

Personalised recommendations